BioScrip, Inc. (BIOS) Misses Q2 EPS by 6c

BioScrip, Inc. (NASDAQ: BIOS) reported Q2 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.9 million versus the consensus estimate of $153.76 million.

For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• BofA Securities previews Netflix (NFLX) earnings
• Morgan Stanley Reiterates Overweight Rating on Befesa SA (BFSA:GR), sees a buying opportunity